Unknown

Dataset Information

0

Freeze-Drying of a Capsid Virus-like Particle-Based Platform Allows Stable Storage of Vaccines at Ambient Temperature.


ABSTRACT: The requirement of an undisrupted cold chain during vaccine distribution is a major economic and logistical challenge limiting global vaccine access. Modular, nanoparticle-based platforms are expected to play an increasingly important role in the development of the next-generation vaccines. However, as with most vaccines, they are dependent on the cold chain in order to maintain stability and efficacy. Therefore, there is a pressing need to develop thermostable formulations that can be stored at ambient temperature for extended periods without the loss of vaccine efficacy. Here, we investigate the compatibility of the Tag/Catcher AP205 capsid virus-like particle (cVLP) vaccine platform with the freeze-drying process. Tag/Catcher cVLPs can be freeze-dried under diverse buffer and excipient conditions while maintaining their original biophysical properties. Additionally, we show that for two model cVLP vaccines, including a clinically tested SARS-CoV-2 vaccine, freeze-drying results in a product that once reconstituted retains the structural integrity and immunogenicity of the original material, even following storage under accelerated heat stress conditions. Furthermore, the freeze-dried SARS-CoV-2 cVLP vaccine is stable for up to 6 months at ambient temperature. Our study offers a potential solution to overcome the current limitations associated with the cold chain and may help minimize the need for low-temperature storage.

SUBMITTER: Aves KL 

PROVIDER: S-EPMC9229831 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Freeze-Drying of a Capsid Virus-like Particle-Based Platform Allows Stable Storage of Vaccines at Ambient Temperature.

Aves Kara-Lee KL   Janitzek Christoph M CM   Fougeroux Cyrielle E CE   Theander Thor G TG   Sander Adam F AF  

Pharmaceutics 20220618 6


The requirement of an undisrupted cold chain during vaccine distribution is a major economic and logistical challenge limiting global vaccine access. Modular, nanoparticle-based platforms are expected to play an increasingly important role in the development of the next-generation vaccines. However, as with most vaccines, they are dependent on the cold chain in order to maintain stability and efficacy. Therefore, there is a pressing need to develop thermostable formulations that can be stored at  ...[more]

Similar Datasets

| S-EPMC8652985 | biostudies-literature
| S-EPMC6956074 | biostudies-literature
| S-EPMC10062427 | biostudies-literature
| S-EPMC8932309 | biostudies-literature
| S-EPMC5161340 | biostudies-literature
| S-EPMC11832850 | biostudies-literature
| S-EPMC7856218 | biostudies-literature
| S-EPMC9988654 | biostudies-literature
| S-EPMC7022747 | biostudies-literature
| S-EPMC3255342 | biostudies-other